Dialysis encephalopathy: a review.
Dialysis encephalopathy (DE) is a distinct neuropsychiatric syndrome typically occurring in patients undergoing longterm hemodialysis. It is characterized by electroencephalographic abnormalities in association with disturbances of speech, cognition, movement, affect, or behavior. Previously thought to be relentlessly progressive, recent evidence linking the illness to aluminum overload has led to advances in prevention and treatment. Early diagnosis aids in the reversal or amelioration of the syndrome and can be of immense value to the patient, the family and involved health personnel. The general features of the syndrome, etiologic considerations, differential diagnosis and treatment are discussed. Three case studies are included to illustrate salient features of the syndrome.
D000328:Adult; D000535:Aluminum / Q000009:adverse effects*; D001927:Brain Diseases / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D002614:Chelating Agents / Q000627:therapeutic use; D003704:Dementia / Q000209:etiology; D004569:Electroencephalography; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008274:Magnesium / Q000097:blood; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000209:etiology; D006435:Renal Dialysis / Q000009:adverse effects* / Q000379:methods; D013064:Speech Disorders / Q000209:etiology
D002614:Chelating Agents; D000535:Aluminum; D008274:Magnesium